摘要
目的分析静脉溶栓联合血管内介入治疗中重症急性脑梗死患者的临床疗效。方法88例中重症急性脑梗死患者,按照掷骰子的方式分为观察组与对照组,各44例。对照组患者予以静脉溶栓治疗,观察组患者予以静脉溶栓联合血管内介入治疗。对比两组治疗效果及美国国立卫生研究院卒中量表(NIHSS)评分。结果观察组治疗总有效率为93.18%,高于对照组的68.18%,差异有统计学意义(P<0.05)。治疗后,观察组NIHSS评分为(5.36±1.45)分,低于对照组的(8.79±1.63)分,差异有统计学意义(P<0.05)。结论为中重症急性脑梗死患者利用静脉溶栓联合血管内介入治疗后能够取得较好的治疗效果,同时还能够有效促进患者的脑部神经功能恢复,改善患者的疾病症状,值得大力推广。
Objective To analyze the clinical efficacy of intravenous thrombolysis combined with intravascular interventional therapy for severe acute cerebral infarction.Methods A total of 88 patients with severe acute cerebral infarction were divided into observation group and control group according to the way of rolling dice,with 44 cases in each group.Patients in the control group received implementation of intravenous thrombolysis,and patients in the observation group received intravenous thrombolysis and intravascular interventional therapy.The therapeutic effect and National Institutes of Health stroke scale(NIHSS)score were compared between the two groups.Results The total effective rate of treatment 93.18%in the observation group was higher than 68.18%in the control group,and the difference was statistically significant(P<0.05).After treatment,NIHSS score in the observation group was(5.36±1.45)points,which was lower than(8.79±1.63)points in the control group,and the difference was statistically significant(P<0.05).Conclusion Combination of intravenous thrombolysis and intravascular interventional therapy has better therapeutic effect on patients with severe acute cerebral infarction,and it can effectively promote the recovery of cerebral nerve function and improve the disease symptoms of patients,which is worthy of extensive promotion.
作者
李巧如
LI Qiao-ru(Union Hospital Affiliated to Fujian Medical University,Fuzhou 350001,China)
出处
《中国现代药物应用》
2021年第19期35-37,共3页
Chinese Journal of Modern Drug Application
关键词
静脉溶栓
血管内介入治疗
中重症急性脑梗死
治疗效果
Intravenous thrombolysis
Intravascular interventional therapy
Severe acute cerebral infarction
Therapeutic effect
